138 related articles for article (PubMed ID: 25840973)
1. Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer.
Mosley M; Knight J; Neesse A; Michl P; Iezzi M; Kersemans V; Cornelissen B
J Nucl Med; 2015 May; 56(5):745-51. PubMed ID: 25840973
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
Torres JB; Mosley M; Koustoulidou S; Hopkins S; Knapp S; Chaikuad A; Kondoh M; Tachibana K; Kersemans V; Cornelissen B
J Nucl Med; 2020 Dec; 61(12):1756-1763. PubMed ID: 32414951
[TBL] [Abstract][Full Text] [Related]
3. A cCPE-based xenon biosensor for magnetic resonance imaging of claudin-expressing cells.
Piontek A; Witte C; May Rose H; Eichner M; Protze J; Krause G; Piontek J; Schröder L
Ann N Y Acad Sci; 2017 Jun; 1397(1):195-208. PubMed ID: 28636798
[TBL] [Abstract][Full Text] [Related]
4. Claudin targeting as an effective tool for directed barrier modulation of the viable epidermis.
Beier LS; Waldow A; Khomeijani Farahani S; Mannweiler R; Vidal-Y-Sy S; Brandner JM; Piontek J; Günzel D
Ann N Y Acad Sci; 2022 Nov; 1517(1):251-265. PubMed ID: 35994210
[TBL] [Abstract][Full Text] [Related]
5. Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.
Cornelissen B; Able S; Kartsonaki C; Kersemans V; Allen PD; Cavallo F; Cazier JB; Iezzi M; Knight J; Muschel R; Smart S; Vallis KA
J Nucl Med; 2014 Dec; 55(12):2026-31. PubMed ID: 25453049
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins.
Veshnyakova A; Piontek J; Protze J; Waziri N; Heise I; Krause G
J Biol Chem; 2012 Jan; 287(3):1698-708. PubMed ID: 22128179
[TBL] [Abstract][Full Text] [Related]
7. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P
Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
[TBL] [Abstract][Full Text] [Related]
9. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
[TBL] [Abstract][Full Text] [Related]
10. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
McLarty K; Cornelissen B; Cai Z; Scollard DA; Costantini DL; Done SJ; Reilly RM
J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
[TBL] [Abstract][Full Text] [Related]
11. Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.
Torres JB; Knight JC; Mosley MJ; Kersemans V; Koustoulidou S; Allen D; Kinchesh P; Smart S; Cornelissen B
Mol Imaging Biol; 2018 Apr; 20(2):292-299. PubMed ID: 28842811
[TBL] [Abstract][Full Text] [Related]
12. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
13. Development, structure, and mechanism of synthetic antibodies that target claudin and Clostridium perfringens enterotoxin complexes.
Orlando BJ; Dominik PK; Roy S; Ogbu CP; Erramilli SK; Kossiakoff AA; Vecchio AJ
J Biol Chem; 2022 Sep; 298(9):102357. PubMed ID: 35952760
[TBL] [Abstract][Full Text] [Related]
14. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
15. Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.
Protze J; Eichner M; Piontek A; Dinter S; Rossa J; Blecharz KG; Vajkoczy P; Piontek J; Krause G
Cell Mol Life Sci; 2015 Apr; 72(7):1417-32. PubMed ID: 25342221
[TBL] [Abstract][Full Text] [Related]
16. Use of Modified
Beier LS; Rossa J; Woodhouse S; Bergmann S; Kramer HB; Protze J; Eichner M; Piontek A; Vidal-Y-Sy S; Brandner JM; Krause G; Zitzmann N; Piontek J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561440
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for
Vecchio AJ; Rathnayake SS; Stroud RM
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
[TBL] [Abstract][Full Text] [Related]
18. cCPE Fusion Proteins as Molecular Probes to Detect Claudins and Tight Junction Dysregulation in Gastrointestinal Cell Lines, Tissue Explants and Patient-Derived Organoids.
Waldow A; Beier LS; Arndt J; Schallenberg S; Vollbrecht C; Bischoff P; Farrera-Sal M; Loch FN; Bojarski C; Schumann M; Winkler L; Kamphues C; Ehlen L; Piontek J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514167
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model.
Shimizu Y; Isoda K; Taira Y; Taira I; Kondoh M; Ishida I
Eur J Pharmacol; 2020 Nov; 887():173596. PubMed ID: 32979353
[TBL] [Abstract][Full Text] [Related]
20. On the interaction of Clostridium perfringens enterotoxin with claudins.
Veshnyakova A; Protze J; Rossa J; Blasig IE; Krause G; Piontek J
Toxins (Basel); 2010 Jun; 2(6):1336-56. PubMed ID: 22069641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
